VIVUS, Inc. (NASDAQ: VVUS) is a pharmaceutical company engaged in developing, acquiring and marketing innovative products to improve quality of life disorders in men and women, with a focus on sexual dysfunction. VIVUS’ goal is to establish a robust pipeline consisting of drug candidates at various stages of development, with a focus on innovative therapies intended to serve large and unsatisfied markets. In addition to the Company’s currently marketed products, MUSE® and ACTIS®, VIVUS is developing products for male erectile dysfunction, female sexual dysfunction, and premature ejaculation. The Company believes that patients with these conditions are not being adequately treated, and VIVUS has the expertise and intellectual property necessary to make meaningful contributions in these areas.
Astra AB; Bio-Medic Institute; Deerfield Management ; MEDA; Paladin; Tanabe